DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,767 filers reported holding DANAHER CORPORATION in Q4 2020. The put-call ratio across all filers is 0.97 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,981,286 | +13.4% | 12,016 | +9.7% | 0.03% | +14.3% |
| Q2 2023 | $2,628,959 | -6.9% | 10,953 | -2.2% | 0.03% | -12.5% |
| Q1 2023 | $2,824,104 | +4.1% | 11,204 | +9.7% | 0.03% | 0.0% |
| Q4 2022 | $2,711,962 | -8.7% | 10,217 | -11.2% | 0.03% | -17.9% |
| Q3 2022 | $2,972,000 | +2.9% | 11,508 | +1.0% | 0.04% | +8.3% |
| Q2 2022 | $2,889,000 | -15.7% | 11,395 | -2.5% | 0.04% | -2.7% |
| Q1 2022 | $3,429,000 | -11.0% | 11,688 | -0.2% | 0.04% | -9.8% |
| Q4 2021 | $3,853,000 | +18.8% | 11,710 | +9.9% | 0.04% | +7.9% |
| Q3 2021 | $3,244,000 | +11.5% | 10,655 | -1.7% | 0.04% | +11.8% |
| Q2 2021 | $2,910,000 | +20.8% | 10,844 | +1.3% | 0.03% | +9.7% |
| Q1 2021 | $2,409,000 | -8.1% | 10,702 | -9.2% | 0.03% | -22.5% |
| Q4 2020 | $2,620,000 | +29.3% | 11,792 | +25.4% | 0.04% | +14.3% |
| Q3 2020 | $2,026,000 | +11.6% | 9,407 | -8.4% | 0.04% | +2.9% |
| Q2 2020 | $1,816,000 | +11.1% | 10,272 | -12.9% | 0.03% | +6.2% |
| Q1 2020 | $1,634,000 | -14.1% | 11,800 | -4.8% | 0.03% | +3.2% |
| Q4 2019 | $1,902,000 | +20.1% | 12,396 | +13.0% | 0.03% | +10.7% |
| Q3 2019 | $1,584,000 | +12.7% | 10,968 | +11.6% | 0.03% | +7.7% |
| Q2 2019 | $1,405,000 | -29.7% | 9,829 | -36.6% | 0.03% | -23.5% |
| Q1 2019 | $1,998,000 | +16.0% | 15,506 | -7.2% | 0.03% | 0.0% |
| Q4 2018 | $1,723,000 | -4.8% | 16,711 | +0.3% | 0.03% | +6.2% |
| Q3 2018 | $1,810,000 | +16.0% | 16,654 | +5.3% | 0.03% | +3.2% |
| Q2 2018 | $1,560,000 | +13.4% | 15,809 | +12.5% | 0.03% | +10.7% |
| Q1 2018 | $1,376,000 | +10.9% | 14,057 | +5.1% | 0.03% | +7.7% |
| Q4 2017 | $1,241,000 | +12.8% | 13,374 | +4.3% | 0.03% | +18.2% |
| Q3 2017 | $1,100,000 | +30.2% | 12,826 | +28.1% | 0.02% | +15.8% |
| Q2 2017 | $845,000 | +15.9% | 10,015 | +17.4% | 0.02% | +5.6% |
| Q1 2017 | $729,000 | -25.8% | 8,532 | -32.7% | 0.02% | -18.2% |
| Q4 2016 | $983,000 | -1.5% | 12,685 | -0.7% | 0.02% | -12.0% |
| Q3 2016 | $998,000 | -8.8% | 12,778 | +17.7% | 0.02% | -21.9% |
| Q2 2016 | $1,094,000 | +10.7% | 10,857 | +3.9% | 0.03% | +3.2% |
| Q1 2016 | $988,000 | +3.7% | 10,454 | +1.5% | 0.03% | 0.0% |
| Q4 2015 | $953,000 | +7.6% | 10,302 | -1.2% | 0.03% | 0.0% |
| Q3 2015 | $886,000 | +13.0% | 10,425 | +13.3% | 0.03% | +19.2% |
| Q2 2015 | $784,000 | -6.7% | 9,205 | -7.4% | 0.03% | -7.1% |
| Q1 2015 | $840,000 | -12.2% | 9,945 | -11.4% | 0.03% | -9.7% |
| Q4 2014 | $957,000 | -3.5% | 11,229 | -14.5% | 0.03% | -8.8% |
| Q3 2014 | $992,000 | -10.7% | 13,126 | -7.4% | 0.03% | -10.5% |
| Q2 2014 | $1,111,000 | +11.8% | 14,169 | +6.4% | 0.04% | +5.6% |
| Q1 2014 | $994,000 | -0.2% | 13,314 | +2.7% | 0.04% | -2.7% |
| Q4 2013 | $996,000 | +6.9% | 12,966 | -3.9% | 0.04% | -11.9% |
| Q3 2013 | $932,000 | +8.1% | 13,490 | -1.3% | 0.04% | 0.0% |
| Q2 2013 | $862,000 | – | 13,670 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RobecoSam USA, Inc. | 74,961 | $7,572,000 | 9.43% |
| Corvid Peak Capital Management, LLC | 250,000 | $25,250,000 | 8.54% |
| CORTLAND ASSOCIATES INC/MO | 310,508 | $31,361,000 | 6.88% |
| Southpoint Capital Advisors LP | 1,250,000 | $126,250,000 | 6.75% |
| GREEN VALLEY INVESTORS LLC | 2,168,594 | $219,027,000 | 6.70% |
| DAVIS-REA LTD. | 75,080 | $7,595,000 | 5.39% |
| CADINHA & CO LLC | 247,143 | $24,961,000 | 5.35% |
| Espalier Global Management LLC | 47,100 | $4,757,000 | 5.25% |
| Spears Abacus Advisors LLC | 398,334 | $40,232,000 | 5.10% |
| GCA INVESTMENT MANAGEMENT, LLC | 158,064 | $15,964,000 | 5.01% |